Initia is pleased to announce an important milestone in the continued expansion of MORENOVA across Southeast Asia: the system has secured permission for import into Singapore for pain management use.

This achievement marks an important step in introducing MORENOVA to the Singapore market and reflects the sustained effort, investment, and collaboration required to establish advanced medical technologies in new regions.

Advancing MORENOVA’s Presence in Singapore

The import permission supports Initia’s broader strategy to expand access to advanced shockwave technology and to work closely with local healthcare professionals as the market develops.

By establishing the regulatory and commercial foundations needed for local market entry, Initia is taking another step toward making MORENOVA available to more clinics and professionals across Singapore.

A Partnership-Driven Milestone

This progress was made possible through close collaboration with Initia’s distributor, AXONVIS, together with its CEO, Porshin Ng, and Oren Barashi, VP Sales & Business Development at Initia.

Their shared commitment, professionalism, and long-term vision continue to support Initia’s development in the region and strengthen relationships with healthcare professionals in Singapore.

Initia looks forward to building on this momentum and continuing to expand access to MORENOVA’s advanced shockwave technology across Singapore.